Comparative effectiveness of natalizumab ocrelizumab in multiple sclerosis: a real-world propensity score–matched study
Background: For treatment of relapsing-remitting multiple sclerosis (RRMS), a broad range of disease-modifying therapies (DMT) is available. However, few comparative effectiveness studies between different drugs have been performed. Objectives: This study aimed to compare the efficacy and treatment...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
SAGE Publishing
2022-12-01
|
| Sraith: | Therapeutic Advances in Neurological Disorders |
| Rochtain ar líne: | https://doi.org/10.1177/17562864221142924 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|